Blocking thromboxane-prostanoid receptor signaling protected animals from lung fibrosis in preclinical models, suggesting a new treatment for IPF — a chronic, progressive lung disorder that often kills within 3-5 years of diagnosis.

Black patients in the ICU were more likely to have low or high blood oxygen levels than white patients, even when a pulse oximeter indicated 92-96% oxygen saturation, Vanderbilt researchers found.

Efforts to correct mistaken or outdated penicillin allergy records are destined to spread to more patient care areas at Vanderbilt University Medical Center.

ICU survivors who have impaired exercise capacity months after discharge may have damaged muscle mitochondria — the energy powerhouses of the cell, Vanderbilt researchers propose.

Using a high-throughput informatics technique and electronic health records, Vanderbilt researchers found that COVID-19 survivors had an increased risk for more than 40 new diagnoses.

President Joe Biden on Wednesday signed into law a broad expansion of health care benefits for millions of veterans exposed to toxic burn pits, and for Robert Miller, MD, professor of Allergy, Pulmonary and Critical Care Medicine, and his Vanderbilt University Medical Center colleagues, the action is a long-awaited victory.

A Vanderbilt study shows that physicians can successfully identify and disprove low-risk sulfa antibiotic allergies using an oral antibiotic challenge in consenting patients prior to solid organ transplant.